Michael Tsaconas is BioCina Adelaide’s Vice President and General Manager, with over 25 years of experience in pharmaceutical manufacturing across liquids, creams, solid oral dose forms, and large molecule drug substance. He has held leadership roles in Quality, Operational Excellence, and Operations at FH Faulding, Mayne Pharma, Hospira, and Pfizer, where he led Adelaide operations that achieved USFDA approval for a biosimilar product in 2020.